You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

6 search results for: upper airway

EAACI 2024 On-Treatment Clinical Remission in <b>Upper</b> and Lower <b>Airway</b>s: Going Beyond Symptom Control
expert video

EAACI 2024 On-Treatment Clinical Remission in Upper and Lower Airways: Going Beyond Symptom Control

Pulmonology
Join global experts for an educational symposium on elevating treatment goals from control to remission in the upper and lower airways.
View more
EAACI 2024 Moving Beyond Control To On-Treatment Clinical Remission
expert video

EAACI 2024 Moving Beyond Control To On-Treatment Clinical Remission

Pulmonology
Watch Prof G. Walter Canonica discuss the need to move beyond disease control to clinical remission in asthma and CRSwNP.
View more
ERS-ISIAN 2023 | Implementation of Guidelines into Daily Practice: Past, Present, and Future
expert video

ERS-ISIAN 2023 | Implementation of Guidelines into Daily Practice: Past, Present, and Future

Rhinology
Dr. Stella Lee explores the past, present and future implementation of guidelines into daily practice
View more
ERS-ISIAN 2023 | From Endotype to Phenotype: Linking Pathophysiology to Burden and Clinical Management for Patients with Uncontrolled and/or Severe CRSwNP
expert video

ERS-ISIAN 2023 | From Endotype to Phenotype: Linking Pathophysiology to Burden and Clinical Management for Patients with Uncontrolled and/or Severe CRSwNP

Rhinology
Prof. Peter Hellings discusses the interconnection between the pathophysiology, burden and clinical management of uncontrolled and/or severe CRSwNP
View more
Dr. Giorgio Canonica Regarding Multidisciplinary Approach
expert video

Dr. Giorgio Canonica Regarding Multidisciplinary Approach

Rhinology
This video clip from the EAACI 2024 symposium highlights that a multidisciplinary approach is essential for the treatment of asthma.
View more
CRSwNP Significantly Affects the Quality of Life of CRSwNP Patients
interactivity

CRSwNP Significantly Affects the Quality of Life of CRSwNP Patients

Rhinology
Explore the factors that contribute to the significant burden of CRSwNP on patient quality of life.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: DenmarkChange country/region